KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Amortization of Deferred Charges: 2009-2022

Historic Amortization of Deferred Charges for Exact Sciences (EXAS) over the last 13 years, with Dec 2022 value amounting to $7.1 million.

  • Exact Sciences' Amortization of Deferred Charges fell 79.00% to -$49.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$33.1 million, marking a year-over-year decrease of 89.11%. This contributed to the annual value of $7.1 million for FY2022, which is 6.64% up from last year.
  • According to the latest figures from FY2022, Exact Sciences' Amortization of Deferred Charges is $7.1 million, which was up 6.64% from $6.7 million recorded in FY2021.
  • In the past 5 years, Exact Sciences' Amortization of Deferred Charges registered a high of $28.6 million during FY2018, and its lowest value of $2.9 million during FY2019.
  • Over the past 3 years, Exact Sciences' median Amortization of Deferred Charges value was $6.7 million (recorded in 2021), while the average stood at $6.4 million.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first slumped by 89.88% in 2019, then surged by 83.43% in 2020.
  • Exact Sciences' Amortization of Deferred Charges (Yearly) stood at $28.6 million in 2018, then plummeted by 89.88% to $2.9 million in 2019, then spiked by 83.43% to $5.3 million in 2020, then rose by 26.02% to $6.7 million in 2021, then grew by 6.64% to $7.1 million in 2022.